ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
goldenchook
|
76 |
33K |
14 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
76
|
33K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
goldenchook
|
160 |
81K |
8 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
160
|
81K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
AGM
|
|
goldenchook
|
10 |
6.1K |
10 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
10
|
6.1K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
goldenchook
|
160 |
81K |
19 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
81K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
goldenchook
|
1.0K |
541K |
84 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1.0K
|
541K
|
84
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
goldenchook
|
160 |
81K |
41 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
81K
|
41
|
|
ASX - By Stock
|
NEU |
Re:
The Field of Play for NEU through the eyes of Ken (AKA The Professor)
|
|
goldenchook
|
29 |
15K |
24 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
29
|
15K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
goldenchook
|
231 |
120K |
19 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
231
|
120K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
The Field of Play for NEU through the eyes of Ken (AKA The Professor)
|
|
goldenchook
|
29 |
15K |
23 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
29
|
15K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
goldenchook
|
231 |
120K |
35 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
120K
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
10K |
4.8M |
15 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
10K |
4.8M |
35 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
35
|
|
ASX - By Stock
|
AVE |
Re:
Ann: First Patient dosed in Phase III insomnia trial
|
|
goldenchook
|
12 |
3.0K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
12
|
3.0K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: First Patient dosed in Phase III insomnia trial
|
|
goldenchook
|
12 |
3.0K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
12
|
3.0K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
goldenchook
|
67 |
14K |
3 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
67
|
14K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
goldenchook
|
67 |
14K |
2 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
67
|
14K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
goldenchook
|
67 |
14K |
5 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
67
|
14K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
goldenchook
|
67 |
14K |
3 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
67
|
14K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
goldenchook
|
67 |
14K |
4 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
67
|
14K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
goldenchook
|
67 |
14K |
4 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
67
|
14K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
goldenchook
|
67 |
14K |
8 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
67
|
14K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
0 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
605
|
273K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
30 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
605
|
273K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
10K |
4.8M |
17 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trofinetide accepted for Priority Review by Health Canada
|
|
goldenchook
|
8 |
4.7K |
41 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
8
|
4.7K
|
41
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
10K |
4.8M |
16 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
10K
|
4.8M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
goldenchook
|
91 |
54K |
65 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
91
|
54K
|
65
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
9.3K |
9 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
40
|
9.3K
|
9
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
9.3K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
40
|
9.3K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
9.3K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
40
|
9.3K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
goldenchook
|
91 |
54K |
15 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
91
|
54K
|
15
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
9.3K |
4 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
40
|
9.3K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
9.3K |
5 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
40
|
9.3K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
goldenchook
|
40 |
9.3K |
6 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
40
|
9.3K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
33 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
605
|
273K
|
33
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
33 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
605
|
273K
|
33
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
goldenchook
|
10K |
4.8M |
30 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
10K
|
4.8M
|
30
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
goldenchook
|
92 |
27K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
92
|
27K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
26 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
605
|
273K
|
26
|
|
Charts
|
NEU |
Re:
Positive Reports
|
|
goldenchook
|
41 |
18K |
23 |
04/03/24 |
04/03/24 |
Charts
|
41
|
18K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
goldenchook
|
130 |
64K |
38 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
130
|
64K
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
goldenchook
|
130 |
64K |
37 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
130
|
64K
|
37
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
goldenchook
|
130 |
64K |
30 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
130
|
64K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
35 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
605
|
273K
|
35
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
22 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
605
|
273K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
17 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
605
|
273K
|
17
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
goldenchook
|
92 |
27K |
14 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
92
|
27K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
goldenchook
|
605 |
273K |
42 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
605
|
273K
|
42
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
goldenchook
|
316 |
164K |
10 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
316
|
164K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
goldenchook
|
316 |
164K |
67 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
164K
|
67
|
|